Leadership & Pay ·
Cocrystal Pharma, Inc. appointed James Sapirstein as Chief Executive Officer, effective June 3, 2026
COCPCocrystal Pharma, Inc.
Cocrystal Pharma, Inc. appointed James Sapirstein as Chief Executive Officer, effective June 3, 2026. Mr. Sapirstein's compensation package includes an annual base salary of $265,000, a 50% performance bonus target, and an initial grant of 235,000 stock options with a $1.05 exercise price. He replaces Co-CEOs Sam Lee and James Martin, who will remain in their roles as President/Chief Scientific Officer and Chief Financial Officer, respectively. Cocrystal Pharma, Inc. is a biopharmaceutical company.